Toxic effects of cis-dichlorodiammineplatinum(II) in man.
about
Interventions for preventing neuropathy caused by cisplatin and related compoundsHaemolytic anaemia after cisplatin treatmentThe implication and potential applications of high-mobility group box 1 protein in breast cancerThe renal effects of N10-propargyl-5,8-dideazafolic acid (CB3717) and a non-nephrotoxic analogue ICI D1694, in miceComparison of cochlear cell death caused by cisplatin, alone and in combination with furosemide.Management of pediatric and adult patients with medulloblastoma.Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.Intestinal and liver toxicity of antineoplastic drugs.Severe sensorimotor neuropathy after cisplatin therapy.Understanding and improving platinum anticancer drugs--phenanthriplatinA retrospective review of the frequency and nature of acute hypersensitivity reactions at a medium-sized infusion center: comparison to reported values and inconsistencies found in literature.Ghrelin partially protects against cisplatin-induced male murine gonadal toxicity in a GHSR-1a-dependent manner.Neurotoxicity caused by the treatment with platinum analogues.Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.Glutamate Receptors in the Central Nucleus of the Amygdala Mediate Cisplatin-Induced Malaise and Energy Balance Dysregulation through Direct Hindbrain Projections.Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot studyLong-term somatic side-effects and morbidity in testicular cancer patients.Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic AgentsEffects of cisplatin on different haemopoietic progenitor cells in miceRandomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatinEffect of diethyldithiocarbamate rescue on tumor response to cis-platinum in a rat model.A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.Impact of denosumab on bone mass in cancer patients.Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicityCrystal structures of organoplatinum complexes containing alkyl-eugenoxyacetate and p-chloro-aniline.Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitroObservational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.Dietary supplementation of coenzyme Q10 plus multivitamins to hamper the ROS mediated cisplatin ototoxicity in humans: A pilot study.Minimal C-terminal modification boosts peptide self-assembling ability for necroptosis of cancer cells.Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle.Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogsCisplatin cytotoxicity is dependent on mitochondrial respiration in Saccharomyces cerevisiae.A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia.A case of massive cisplatin overdose managed by plasmapheresis.Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity.Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.
P2860
Q24236661-1BC55258-F840-46FF-9367-155F7CA03953Q24551040-74A8E3C2-1732-47E0-86A7-F766F714B933Q26744069-B84B8006-8E0A-4EA1-B634-DC4EF88B1177Q28333726-A1DC5E71-1951-4F97-8656-CC704BE8F7D4Q30440477-47230BE6-49A1-495E-83B3-1566944E43F2Q30847947-B9D003F0-F1FC-4106-8974-82535D6EE2D6Q33382359-3443E1DE-54C1-48BF-BF1D-E86657D43D54Q33493799-F6BB6A2C-1965-41A9-9438-245A223983A3Q33605823-4DEE45FB-0B32-499D-9EC8-279C9673DA64Q33622080-3DA2EFE6-2E5D-4BC6-9C07-B3E1F44524BDQ34396623-0CE1E2E0-04F5-44CD-A0F7-D434B097C77BQ34648601-65F0BA97-3C45-43F4-9094-CE12707C0DF8Q35201327-B034219E-DFB6-43F0-ADC7-E8B56C9F5229Q35692169-EA918A15-E3F0-4E44-9DB1-32E4845D3685Q35747835-16F7FB85-2C3A-4B4F-95FE-787DA52CBE1DQ35916433-99DE5CFD-E326-488D-B48A-040E1F868CFAQ35975860-398C60AF-7D93-4726-A01C-FD6EC2D831A1Q35981475-5FFC5463-488D-4D6A-B705-B9E5B4BEC451Q35990617-47640ADA-EF20-440B-B937-F70196A39008Q36047032-3100357E-3554-433C-9031-EC85E51178E1Q36134463-867250E0-CD10-426F-8FAB-543C418795DBQ36406886-D37F6D4C-1D23-413A-BBA9-BA09CCF680CAQ36785185-ABBE0048-901B-49AF-BAAC-BA51FC5B844BQ37000157-519E1AEF-190B-4E15-BEAA-2E58BE60F7BCQ37044941-578D520C-AF7C-4771-B356-A245D51658E1Q37193286-90386D2E-60A3-43A8-8E57-4C58F4219A57Q37417127-E2589FEF-9001-4E19-9AA6-5F30FC3D13AEQ37478015-702EF2B9-3D3B-45FC-8E3C-44C1B34C6298Q37653327-8B2BAC57-D270-4BE7-9144-735C71857EA2Q38777495-E9CDB1A3-55A3-4500-BE4B-1AC99611BA44Q39806365-365F8BF0-25DF-49F9-8A24-0FCCBDE2BAB9Q42140523-F832170A-7A94-4630-9A8D-B9FD67D846C7Q42148759-2B2B9ECA-95F9-4747-AD18-9F024A39277EQ42329874-13292A6D-A6FF-4AFE-BC98-65CA731278F5Q42383916-CAE44D11-4318-4043-B1DE-8E25082741E1Q42431770-BF04C540-43E1-4659-A725-22DBDE919749Q43553538-08277238-A70C-43A8-88E5-076664F0331FQ45159072-188B2C42-B43F-4A22-A9D9-4B6085BAEAA6Q55281223-2F1760F7-A005-48D0-837E-FD44D02B31A2
P2860
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
description
1979 nî lūn-bûn
@nan
1979 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
@ast
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
@en
type
label
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
@ast
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
@en
prefLabel
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
@ast
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
@en
P2093
P1476
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
@en
P2093
Reddick RL
Reichert CM
Rozencweig M
Schilsky R
Von Hoff DD
P304
P577
1979-09-01T00:00:00Z